Rheumatoid Arthritis

The benefits of exercise to combat the effects of musculoskeletal conditions have been well-documented. Take this quiz to test your knowledge of sports and exercise medicine in rheumatology.

An assay designed to track TNF counts in recently-treated RA patients found that early reduction of the protein could indicate future problems for the patient.

ABP 798, a biosimilar candidate for rituximab, met pharmacokinetic, efficacy, and safety endpoints in a trial among participants with rheumatoid arthritis.

Madelaine A. Feldman, MD, FACR, shares about the current standard treatment rheumatoid arthritis and the hurdles to providing optimal treatment.

The investigators used FDG PET-CT to detect myocardial inflammation in RA patients without clinical heart failure.

Researchers identify influential factors on hand function in rheumatoid arthritis.

This study appears to confirm the role of B cells in the early pathogenesis of RA and sheds light on an avenue for further investigation.

The interaction of anticitrullinated protein antibody and rheumatoid factor may foretell the response to treatment in patients with rheumatoid arthritis.

Here: 5 challenging questions to test your knowledge.

The smaller, incomplete study is looking into both the efficacy and safety of the longtime therapy for patients with RA.

Scroll through the slides for a review of the many options available to help reduce pain and improve function.

The ACTPen was approved on the basis of a pair of clinical trials presented at the 2018 American Society for Clinical Pharmacology & Therapeutics Annual Meeting.

Flares of rheumatoid arthritis have been linked to higher disease activity, lower quality of life, and increased radiographic progression.

Speaking ambitiously, determining the right tests and initial therapies for patients with rheumatoid arthritis could become optimized.

Belgian researchers sought to determine which patients are appropriate candidates for tapering biologics. In this article, we summarize their findings.

How will you respond to patients who ask about treating rheumatoid arthritis with cannabinoids?

What next when methotrexate monotherapy fails? The answer-and 4 more questions on RA treatment-can be found here.

Recent findings allay concerns about increased costs and rates of adverse events related to TTT strategies.

What’s new: biologic tapering, high-dose influenza vaccine, real-time patient input.

New data shows patients with rheumatoid arthritis do not change their current treatment to reach a “treat-to-target” goal for low disease activity.

A strategy to boost the immune response to vaccination in patients with seropositive rheumatoid arthritis.

Two recent studies address expectations and outcomes following knee and hip replacement in patients with rheumatoid arthritis.

Answer these 8 questions to test your knowledge of the latest RA research findings.

Patients with rheumatoid arthritis who had inadequate response to previous biologic disease-modifying antirheumatic drugs found greater pain relief when taking 2 mg or 4 mg of baricitinib compared with placebo.

The findings led the team to believe a focus on treatment strategy, rather than disease activity, is more indicative of aortic distensibility improvement.